"GSK said in a statement it would pay the fines through existing cash resources."
Well, bully for GlaxoSmithKline, being able to empty out their change jar and rummage around down the back of the sofa and come up with $3bn in fines for fraudulent activity. And then the drug companies wonder how they get a reputation for arrogance and greed.
Tuesday, July 03, 2012
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment